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Background: The modifications of cholesterol metabolism associated with aging are ill-defined. 
The objective of this study was to define age-associated alterations of the different metabolic 
pathways controlling cholesterol homeostasis by analyzing circulating sterols.
Methods: We analyzed serum samples collected from 201 adult (75 male, 126 female) subjects 
within the epidemiological MICOL study (Multicentrica Italiana Colelitiasi). The age range 
was 38–79 years; 103 had evidence of gallstones. The concentrations of the different sterols, 
recognized as markers of the main pathways of cholesterol homeostasis, were analyzed by gas 
chromatography–mass spectrometry, including lathosterol (synthesis), campesterol and sitosterol 
(absorption), and 7α-hydroxy-4-cholesten-3-one (degradation to bile acids).
Results: A significant direct correlation was detected between age and cholesterol levels (r=0.34, 
P,0.01). The lathosterol/cholesterol ratio was lower in older age quartiles (P,0.05 by analysis of 
variance), with an inverse correlation between the lathosterol/cholesterol ratio and age (r=−0.32, 
P,0.01). Such correlation was particularly evident in females. The campesterol/cholesterol and 
sitosterol/cholesterol ratios were inversely correlated with aging in control, but not in gallstone 
patients. The levels of 7α-hydroxy-4-cholesten-3-one were not correlated with age.
Conclusion: These data show a reduction of cholesterol synthesis with aging which is associ-
ated with increased circulating cholesterol levels. The finding might be related to a reduced 
metabolic need for cholesterol in advancing age, leading to a downregulation of the main 
mechanisms of cholesterol intake in the liver. A different age-related behavior was observed in 
gallstone-free versus gallstone patients regarding cholesterol absorption. The possible impli-
cations in terms of the pharmacological management of hypercholesterolemia in the elderly 
remain to be defined.
Keywords: aging, cholesterol metabolism, cholesterol synthesis, gallstone disease, 
 cardiovascular risk
Introduction
The influence of aging on cholesterol homeostasis in humans is poorly defined. 
A number of epidemiological studies suggest that serum cholesterol levels tend to 
increase in adult age, but subsequently decrease in the very elderly.1 On the other hand, 
the impact of serum cholesterol as a cardiovascular risk factor is debated2 and the use 
of cholesterol-lowering agents in old age is extremely controversial.3–6
Whereas the prevalence of cholesterol gallstone disease increases with  advancing 
age,7 the underlying mechanisms are not well understood, and the presence of metabolic 
alterations themselves as predisposing factors of gallstone disease is also a matter of 
debate.8,9
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Clear-cut evidence on specific alterations of cholesterol 
metabolism associated with old age is presently missing, 
mainly due to the complexity of the studies of clinical 
pathophysiology and, consequently, to the limited number of 
observations. Data in human males, however, have shown a 
reduction in the turnover of low density lipoprotein (LDL)10 
and other reports seem to suggest that a reduction in the 
conversion of cholesterol to bile acid takes place.11–13
Likewise, the presence of specific metabolic alterations 
in gallstone disease has been postulated in the past.14,15 
Once again, the rather limited number of patients and tissue 
samples in individual reports makes it extremely difficult to 
achieve definite conclusions.
In the last few decades, the analysis of circulating levels of 
cholesterol precursors, plant sterols, and hydroxylated  sterols 
as metabolic markers has allowed the investigation of the 
individual steps of cholesterol balance (synthesis,  absorption, 
degradation to bile acids) in broader populations.
Here, we attempted to provide a systematic investigation 
on the effects of aging on the different metabolic steps of 
cholesterol homeostasis; this was made possible thanks to 
an epidemiological study conducted in Northern Italy, which 
allowed the collection of clinical information and serum 
samples in a large community population. Alterations related 
with gallstone disease were also investigated.
Subjects and methods
study population
The Multicentrica Italiana Colelitiasi (MICOL) project was 
a population-based, cross-sectional study carried out in Italy. 
Complete details on the study protocol have been published 
elsewhere.16 The project plan included two cross-sectional 
surveys; the first began in 1985 and was completed in 1988 
and the second survey was carried out on the same subjects 
10 years later in order to estimate the incidence of gallstone 
disease and its natural history. Seven of the original operative 
units, including the Unit of Modena, were able to complete 
the second survey.
The re-examination took place between 1995 and 1998.17 
Subjects with gallstones or a history of cholecystectomy for 
gallstones at the first survey were recorded.
Consistently with the first survey, the screening protocol 
included upper abdominal ultrasound, physical examination, 
fasting blood specimen collection, and administration 
of a questionnaire, which was administered by each 
 operative unit.
In the present paper, we analyzed serum samples from 
201 subjects over a rather wide age range (38–79 years); 75 of 
them were males, 126 females; 103 had clinical evidence of 
gallstones and the remaining 98 were treated as control subjects; 
samples were collected within the Modena cohort in the 1995–
1998 re-examination phase and stored at −80°C thereafter until 
analyzed. Additional relevant clinical information, including 
serum lipid levels and presence/absence of gallstone disease, 
was collected from the inherent database. The levels of serum 
lipids, including total cholesterol, were measured by standard 
automated analysis on samples obtained in the morning.
The study has been conducted in conformity with the 
most recent version of the Declaration of Helsinki and has 
been approved by the Ethical Committee of the Province of 
Modena.
Analysis of circulating lathosterol,  
plant sterols, and hydroxysterols
Quantitative evaluation of lathosterol and plant sterols 
(campesterol and beta-sitosterol) in serum was performed 
by gas chromatography–mass spectrometry (GC-MS) as 
previously described.18 After the addition of deuterated 
lathosterol (0.5 µg) and 5α-cholestane (0.5 µg) as internal 
standards to 0.1 mL serum samples, alkaline hydrolysis was 
carried out and sterols extracted with petroleum ether. The 
organic phase was evaporated to dryness under a stream of 
nitrogen and sterols converted into trimethylsilyl ethers with 
trimethylsilylimidazole: piperidine (1:1) before analysis by 
GC-MS.
Serum levels of 7α-hydroxy-4-cholesten-3-one (C4) were 
analyzed as previously described.13,19 After the addition of 
19-hydroxycholesterol (250 ng) as the internal standard to 
0.5 mL of serum, the sample was diluted with physiological 
solution and C4 was extracted with chloroform/methanol 
(2:1, v:v). Purification by solid phase extraction with a 
silica cartridge column (Supelclean LC-Si; Supelco Inc., 
St Louis, MO, USA) was performed; the oxysterol fraction 
was evaporated and sterol converted into trimethylsilyl 
ethers by the addition of 50 µL of trimethylsilylimidazole: 
piperidine (1:1) at room temperature for 20 minutes. After 
evaporation, the derivatives were dissolved in hexane. 
 Aliquots (1–2 µL) of the silylated mixtures were injected 
for GC-MS analysis.
GC-MS analysis was carried out using a Thermo  Finnigan 
GC-Q instrument (Waltham, MA, USA), as previously 
described.18,19
In previous reports, the lathosterol/cholesterol ratio 
has shown a strict correlation with whole body cholesterol 
synthesis, measured with the direct balance method, under 
different experimental conditions,20 and therefore, is widely 
accepted as an index of cholesterol synthesis. Likewise, the 
sitosterol/cholesterol and campesterol/cholesterol ratios were 
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considered as markers of intestinal cholesterol absorption, 
according to the literature.21
The absolute serum concentration of C4 was used as a 
marker of bile acid synthesis and of the activity of cholesterol 
7α-hydroxylase, the limiting enzyme of the metabolic 
pathway.19,22
statistical analysis
Whenever appropriate, continuous variables were expressed 
as the mean value and SD.
The patients were stratified into age quartiles; the sig-
nificance of the differences of continuous variables between 
age quartiles was performed by one-way analysis of variance 
(ANOVA). The difference between individual groups was fur-
ther evaluated by means of Bonferroni post hoc analysis.
Linear correlation analysis was performed using the least 
squares method.
The significance of the differences between gallstone-free 
and gallstone patients was evaluated by Student’s t-test for 
independent data.
Significance was accepted at the P,0.05 level.
Statistical analysis was performed by means of SPSS 
software (v17 for Windows; SPSS Inc., Chicago, IL, USA) 
on a PC-IBM compatible platform.
Results
A direct correlation was detected between age and serum 
levels of total cholesterol, as shown in Figure 1 (r=0.34, 
P,0.01). A significant between-group difference was 
also detected by one-way ANOVA (Table 1). When the 
significance was further tested by Bonferroni’s test, a dif-
ference was detected between the youngest quartile and 
all other age groups, but not between the oldest ones; this, 
together with the visual inspection of the data presented in 
Figure 1, suggests a trend for serum cholesterol to plateau 
when approaching the oldest age groups.
The correlation between serum cholesterol and age 
was observed in both gallstone and gallstone-free subjects 
(respectively, r=0.28 and r=0.46, P,0.01 for both; data not 
shown).
Such correlation was particularly evident in female sub-
jects (n=126; r=0.43, P,0.01), whereas in males, a trend 
was present, but did not reach statistical significance (n=75; 
r=0.19, P,0.1; data not shown).
Figure 2 illustrates the relationship between the 
lathosterol/cholesterol ratio, an index of cholesterol syn-
thesis, and age. In the whole population (upper panel) a 
significant inverse correlation is present (r=−0.32, P,0.01). 
One-way ANOVA confirmed the presence of a significant 
difference among different age groups and Bonferroni’s test 
once again showed a statistical significance only between the 
younger age group and the remaining ones (Table 1).
As shown in the figure (middle and lower panel), the 
inverse correlation was detected regardless of the presence 
or absence of gallstone disease.
As observed with serum cholesterol, such correlation was 
highly significant in females (r=−0.47, P,0.01), whereas 
in male subjects, while the negative trend was present, it 
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Figure 1 Correlation between serum cholesterol levels and age.
Notes: Individual data points are shown for 201 subjects; r=0.34; P,0.01, linear regression analysis.
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Figure 2 Correlation between serum lathosterol to cholesterol ratio, a marker of cholesterol synthesis, and age. (A) Individual data points are shown for all subjects (n=201) 
of the studied cohort; r=−0.32; P,0.01, linear regression analysis; (B) data points are shown for gallstone-free subjects (n=98); r=−0.48; P,0.01, linear regression analysis; 
(C) data points are shown for gallstone patients (n=103); r=−0.28; P,0.01, linear regression analysis.
Table 1 serum levels of total cholesterol and other sterols in the different age quartilesa
Age range Cholesterol* 
(mg/dL)
Latho/Ch* 
(μg/100 mg)
C4 
(μg/dL)
Campe/Ch 
(μg/100 mg)
Sito/Ch 
(μg/100 mg)
38–53 191±32** 122±54** 1.16±1.48 192±119 391±235
53–62 217±42 87±34 1.01±1.08 171±94 378±213
62–68 229±41 86±48 1.19±1.49 142±72 306±271
68–79 226±38 78±40 0.99±0.68 164±133 373±302
Notes: aData are presented as mean value and sD; *P,0.01 among age quartiles, one-way analysis of variance; **P,0.05 versus all remaining groups, Bonferroni’s test.
Abbreviations: latho/Ch, lathosterol to cholesterol ratio; C4, 7α-hydroxy-4-cholesten-3-one; Campe/Ch, serum campesterol to cholesterol ratio; sito/Ch, serum 
sitosterol to cholesterol ratio.
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did not reach statistical significance (r=−0.20, P,0.1; data 
not shown).
According to previous evidence, a decrease in the mark-
ers of bile acid synthesis may have been expected with 
aging.11–13 Instead, no correlation was detected between age 
and serum C4, as shown in Table 1 and Figure 3.
A peculiar behavior was observed with regards to the 
markers of intestinal cholesterol absorption as related to 
age. A trend toward an inverse correlation was detected 
in the whole patient group, which did not reach statistical 
significance (respectively, r=−0.13 for the campesterol/
cholesterol ratio and r=−0.09 for the sitosterol/cholesterol 
ratio, data not shown). When the population was sub-
divided into the two groups according to the presence or 
absence of gallstones, distinct patterns were observed. 
As shown in Figure 4, a significant inverse correlation 
between age and the campesterol/cholesterol ratio was 
present in gallstone-free subjects whereas no correlation 
was observed in gallstone patients. A similar trend was 
observed for the sitosterol/cholesterol ratio (r=−0.23 in 
controls, P,0.05; r=−0.009 in gallstone patients, P,0.1) 
(data not illustrated).
Finally, the levels of the different metabolic biomarkers 
were compared in gallstone and gallstone-free subjects. 
The serum lathosterol/cholesterol ratio was significantly 
higher (P,0.05) in gallstone subjects compared to controls 
(respectively, 101±51 versus [vs] 85±42 µg/100 mg). The 
levels of serum C4 tended to be higher in gallstone subjects, 
even if the difference did not reach statistical significance 
(1.24±1.30 vs 0.93±1.12 µg/dL, P=0.07) mainly because 
of the high degree of dispersion of the experimental data. 
No difference was detected in the markers of cholesterol 
absorption: campesterol/cholesterol ratio: 169±118 vs 
165±96 µg/100 mg; sitosterol/cholesterol ratio: 361±256 vs 
363±213 µg/100 mg (P.0.1, data not illustrated).
Discussion
The aim of the present paper was to clarify the alterations 
of cholesterol metabolism associated with aging, utilizing a 
large cross-sectional population of non-hospitalized subjects, 
most of whom can be considered healthy except for the pres-
ence of gallstone disease.
First of all, a significant correlation was detected between 
age and serum cholesterol, even if the trend tended to pla-
teau in the higher age quartiles. The finding is in agreement 
with previous evidence from Ericsson et al,10 where the 
LDL catabolic rate was found to be significantly decreased, 
consistently with reduced LDL turnover. In our population, 
aging was also inversely correlated with the lathosterol/
cholesterol ratio, suggesting a reduction of whole body 
(and presumably hepatic) cholesterol synthesis. As far as 
we know, this is the first report documenting a reduction 
of cholesterol synthesis with ongoing age; a recent study 
carried out in a Northern Europe population also showed an 
increase in serum cholesterol and failed to show any changes 
in the markers of cholesterol synthesis.23 Additional evidence 
from another Northern Europe cohort of very old age (up to 
85 years) showed a tendency for serum cholesterol levels to 
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plateau, and even to decrease in women, with no significant 
changes in lathosterol levels.24
It is generally recognized that cholesterol synthesis and 
LDL uptake in most experimental conditions are coordinately 
regulated and undergo strict homeostatic control, where the 
liver plays a central role;25 such regulation involves molecu-
lar sensors of cellular sterol content, the sterol regulatory 
element binding proteins (SREBPs) and SREBP-cleavage 
activating protein (SCAP).26 The data of the present paper 
cannot elucidate the pathways undergoing the observed 
changes in cholesterol homeostasis. Nonetheless, our find-
ings, taken together with evidence from the literature, are 
consistent with the view of a reduction in the metabolic need 
of cholesterol with aging; this might explain on one hand 
the reduction of LDL uptake (and consequently, the increase 
of serum cholesterol levels), and on the other, the reduced 
expression and/or activity of the key enzymes of choles-
terol synthesis. This is in agreement with the reduction of 
hydroxymethylglutaryl-CoA reductase expression observed 
in aged rats.27 The involvement of nuclear receptor-mediated 
 signaling pathways in this regard is plausible, as described 
in an experimental mouse model.28
When segregating our data by sex, the correlation with 
serum cholesterol and with the lathosterol/cholesterol ratio 
was highly significant in females; in males, a distinct trend 
was observed with either parameter but did not reach signifi-
cance. The finding might be related to the smaller number of 
observations; however, it cannot be excluded that sex-specific 
alterations might take place, as suggested by the different 
age-related profiles of plasma cholesterol.12,16
According to previous reports in the literature, both from 
our group and from other authors,11–13 a negative correla-
tion between age and bile acid synthesis might have been 
expected. However, no such trend was observed. A similar 
finding was noted by Gälman et al.23 We have no clear expla-
nation for this discrepancy; it has to be underlined that the 
subjects in the present study were randomly selected from the 
general population, whereas the patients studied in our previ-
ous reports12,13 were hospitalized. In addition, as pointed out,23 
the population of the older studies was much smaller.
The profile of the serum markers of cholesterol absorp-
tion was peculiar: a significant inverse correlation with age 
was observed in gallstone-free subjects but not in gallstone 
patients, making the correlation non-significant in the whole 
cohort. This finding is in partial agreement with the already 
mentioned reports, where a decrease in markers of cholesterol 
absorption was described with aging23,24 and fits with the view 
of a reduction in cholesterol requirement.
The role of intestinal cholesterol absorption in the 
pathogenesis of gallstone disease is debated (reviewed by 
Portincasa et al).29 The present data are consistent with 
a trend toward a decrease in cholesterol absorption with 
aging, which does not take place in gallstone patients. Due 
to the design of the study, such data, however, cannot allow 
extensive speculations in terms of pathogenesis. It has to be 
further considered that the markers of cholesterol absorption 
were similar in the two groups.
Our findings also show a slight but significant increase 
in the markers of cholesterol synthesis and an increase, 
though not reaching statistical significance, of bile acid 
production in gallstone patients.
The role of perturbations of cholesterol homeostasis 
as predisposing factors for gallstone formation is debated. 
Together with the regulatory role of the physical–chemical 
properties of the recirculating bile acid pool,30 it has been 
postulated that opposing changes of cholesterol production 
and degradation might increase biliary cholesterol saturation 
and predispose to stone formation,14 even if this was not 
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confirmed by enzyme activity analysis in the liver tissue.15 
Further, more recent evidence has demonstrated an increase, 
rather than a decrement, in metabolic markers of bile acid 
synthesis.31,32 This has been interpreted as a manifestation 
of subclinical bile acid malabsorption, which in peculiar 
subsets might favor the supersaturation of bile. The present 
data are largely consistent with the literature; the proportional 
changes in serum lathosterol and C4 are similar to those 
described by Muhrbeck et al,31 supporting the possibility 
that in epidemiological-size cohorts, gallstone disease may 
associate with metabolic perturbations with a likely patho-
genetic significance. The possible role for such alterations in 
individual subjects, however, can hardly be defined.
The potential implications of the alterations observed 
with aging deserve consideration.
The management of hypercholesterolemia in elderly sub-
jects is controversial; whereas the benefits of statin treatment 
are evident also in older age,4,33 direct evidence in the very 
elderly is scarce, and mostly, treatment with lipid-lowering 
agents may associate with important adverse events due to the 
different pharmacokinetic and pharmacodynamic responses 
of the individual patient.34 Furthermore, in elderly people, 
the correlation between circulating cholesterol and cardio-
vascular disease is weaker,2 emphasizing the possible role 
of other biological components, including inflammation, as 
risk determinants in this population.
Epidemiological evidence has even suggested that low 
plasma cholesterol levels, as well as low levels of choles-
terol synthesis and absorption markers, may bear a negative 
prognostic significance.24 In particular, serum non-high-
density lipoprotein cholesterol was found to bear a protec-
tive effect in elderly subjects with good functional status.35 
More recent evidence showed an inverse correlation between 
serum cholesterol and non-cardiovascular mortality.36 Indeed, 
patterns of low cholesterol levels may associate with a 
 comorbidity and frailty profile.37 On the other hand, it appears 
clear that spontaneous and drug-induced low cholesterol levels 
(so-called passive and active cholesterol lowering) may associ-
ate with different clinical pictures and prognosis.24
Furthermore, the relationship between plasma cholesterol 
and cognitive function is complex and as yet incompletely 
understood.38
This considered, the treatment decision is obviously artic-
ulated and accurate consideration of the risk–benefit ratio, 
together with the multi-dimensional evaluation of comorbid-
ity and frailty status needs to be carried out.39 Being aware of 
a possible decrease in cholesterol synthesis and/or absorption 
in old age should not necessarily prevent health care providers 
from treating with statins or ezetimibe, respectively, if the 
balance between the benefit–risk profile and the functional 
status warrants this so. Useful information might derive from 
the identification of older patients as “hyperabsorbers” or 
“hypersynthezisers”, which would potentially orient toward 
more specific treatment approaches.40 In the absence of such 
evaluation as routine analysis, careful clinical judgment will 
orient the management choice.
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